Efficacy, Safety, and Medication Cost Implications of Adalimumab 40 mg Weekly Dosing in Psoriasis Patients with Sub-Optimal Response to 40 mg Every Other Week Dosing: Results from an Open-Label Study
British Journal of Dermatology, 05/11/2012Leonardi C et al.
Most patients did not require dose escalation. By 12 weeks after dose escalation, one–quarter achieved substantial clinical improvement. Safety results were similar between patients who dosage–escalated and those who did not.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.